Clinical Practice Research Datalink

10th April 2019

GP practices in Stockport have an opportunity to gain useful feedback for improving patient care, contribute to medical research and even earn some money by joining Clinical Practice Research Datalink (CPRD).  More than 1350 practices already take part, contributing data which can be used to prove the safety of drugs/vaccines.  A key benefit is receiving regular practice-level prescribing and patient safety quality improvement reports, which help GPs to review patient care.

Find out more here about how data can be used to improve patient care.

Type 2 Diabetes clinical trial

CPRD are also recruiting for a pragmatic clinical trial, DECIDE, which is sponsored by Liverpool University. It is a Type 2 Diabetes trial investigating the effectiveness of Dapagliflozin compared to Standard of Care.

What to expect

• CPRD will identify eligible patients via the platform and crest a list via EMIS.
• GP to check the eligible list for patients who they would be happy to move onto second line treatment.
• Practice to call these patients to invite them to make an appointment to discuss the study.
• GP receives informed consent from the patient and randomise to Dapagliflozin or Non-SU (standard care) or SU (standard care), using the online platform
• No study visits are required after a patient is enrolled as data is collected through EMIS Web.
• Patient Activity: Patient will complete 6 monthly study questionnaires online, for two years.

Trial payments:  Practice Set up –  £250 / Per Patient recruited-  £300

If you would like to do DECIDE, please list it as your reason for joining. Please note that DECIDE is not compulsory and please don’t let it put you off signing up. Many of CPRD’s practices just contribute non-identifiable data which supports very important research without increasing their workload.

If you would like any further information please contact Catheryn.evans@mhra.gov.uk.  To sign up for please click this: CPRD.